New study shows promising diagnosis of multiple sclerosis from images of the eye

byDurham UniversitySaliency maps generated for eight SLO images and OCT thickness maps of the total retina of (A) HC and (B) MS subjects from the test dataset when the best-performing model trai

Updated on: July 31,2024

New study shows promising diagnosis of multiple sclerosis from images of the eye

byDurham UniversitySaliency maps generated for eight SLO images and OCT thickness maps of the total retina of (A) HC and (B) MS subjects from the test dataset when the best-performing model trai

Updated on:July 31,2024

Arterial stiffening linked to Alzheimer's disease

by Paul Govern,Vanderbilt UniversityCredit: Pixabay/CC0 Public DomainA research team from Vanderbilt University Medical Center reports inNeurologythat greater stiffening of the aorta

Updated on: May 22,2024

Arterial stiffening linked to Alzheimer's disease

by Paul Govern,Vanderbilt UniversityCredit: Pixabay/CC0 Public DomainA research team from Vanderbilt University Medical Center reports inNeurologythat greater stiffening of the aorta

Updated on:May 22,2024

Routine brain scanning may improve clinical care for people with psychosis

by University of OxfordCredit: AI-generated imageRoutine brain scanning in people experiencing psychosis could help to identify underlying physical conditions that are causing their symptoms, acc

Updated on: February 05,2024

Routine brain scanning may improve clinical care for people with psychosis

by University of OxfordCredit: AI-generated imageRoutine brain scanning in people experiencing psychosis could help to identify underlying physical conditions that are causing their symptoms, acc

Updated on:February 05,2024

Predicting change in the Alzheimer's brain

by Larry Hardesty,Massachusetts Institute of TechnologyMIT researchers are developing a computer system that uses genetic, demographic, and clinical data to help predict the effects of disease o

Updated on: February 26,2024

Predicting change in the Alzheimer's brain

by Larry Hardesty,Massachusetts Institute of TechnologyMIT researchers are developing a computer system that uses genetic, demographic, and clinical data to help predict the effects of disease o

Updated on:February 26,2024

Experimental drug shows promise in treating Alzheimer's disease

by American Society of AnesthesiologistsAn experimental drug shows promise in treating Alzheimer's disease by preventing inflammation and removing abnormal protein clumps in the brain that are ass

Updated on: March 07,2024

Experimental drug shows promise in treating Alzheimer's disease

by American Society of AnesthesiologistsAn experimental drug shows promise in treating Alzheimer's disease by preventing inflammation and removing abnormal protein clumps in the brain that are ass

Updated on:March 07,2024

Tau does not stabilize microtubules, challenges approach to treating Alzheimer's

by Drexel UniversityThis image represents the role of tau and MAP6 in regulating the stable (green) and dynamic (red) parts of a neuron's microtubules. Depleting tau from cultured rat neurons

Updated on: April 02,2024

Tau does not stabilize microtubules, challenges approach to treating Alzheimer's

by Drexel UniversityThis image represents the role of tau and MAP6 in regulating the stable (green) and dynamic (red) parts of a neuron's microtubules. Depleting tau from cultured rat neurons

Updated on:April 02,2024

Alzheimer's drug development pipeline: Promising therapies, pharma investment drive momentum in clinical trials

by University of Nevada, Las VegasAgents in clinical trials for treatment of Alzheimer's disease in 2023 (from ClinicalTrials.gov as of the index date of January 1, 2023). The inner ring show

Updated on: April 16,2024

Alzheimer's drug development pipeline: Promising therapies, pharma investment drive momentum in clinical trials

by University of Nevada, Las VegasAgents in clinical trials for treatment of Alzheimer's disease in 2023 (from ClinicalTrials.gov as of the index date of January 1, 2023). The inner ring show

Updated on:April 16,2024

Dementia and COVID-19: Determinants of infection and mortality

by IOS PressFactors associated with 60-day mortality in dementia patients infected with SARS-CoV-2. Credit:Journal of Alzheimer's Disease(2022). DOI: 10.3233/JAD-220369The elderly

Updated on: May 06,2024

Dementia and COVID-19: Determinants of infection and mortality

by IOS PressFactors associated with 60-day mortality in dementia patients infected with SARS-CoV-2. Credit:Journal of Alzheimer's Disease(2022). DOI: 10.3233/JAD-220369The elderly

Updated on:May 06,2024

MAO is a possible Alzheimer's disease biomarker

by American Chemical SocietyResearchers used mice studies to reveal that MAO activity (yellow) is directly correlated with the progression of Alzheimer's disease and may be used to stage the

Updated on: March 30,2024

MAO is a possible Alzheimer's disease biomarker

by American Chemical SocietyResearchers used mice studies to reveal that MAO activity (yellow) is directly correlated with the progression of Alzheimer's disease and may be used to stage the

Updated on:March 30,2024

Study links premature development of human neurons to brain developmental disorders

byVIB (the Flanders Institute for Biotechnology)Mouse cortex (in blue) transplanted with human neurons (in green). Credit: VIBThe mechanisms underlying intellectual disabilities or autism remain

Updated on: August 08,2024

Study links premature development of human neurons to brain developmental disorders

byVIB (the Flanders Institute for Biotechnology)Mouse cortex (in blue) transplanted with human neurons (in green). Credit: VIBThe mechanisms underlying intellectual disabilities or autism remain

Updated on:August 08,2024

GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

by Emory UniversityGluN3A (in the diagram, NR3) is an inhibitory subunit within NMDA receptor assemblies, which function as glutamate-gated cation channels. GluN3A is a key regulator of neuronal

Updated on: March 30,2024

GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

by Emory UniversityGluN3A (in the diagram, NR3) is an inhibitory subunit within NMDA receptor assemblies, which function as glutamate-gated cation channels. GluN3A is a key regulator of neuronal

Updated on:March 30,2024

Mechanisms of phototherapy of Alzheimer's disease during sleep and wakefulness

by Frontiers JournalsPhotobiomodulation of brain cleansing of beta-amyloid during sleep. Credit: Frontiers JournalsPhotobiomodulation during sleep turns the brain into a washing machine, helping to cl

Updated on: March 02,2024

Mechanisms of phototherapy of Alzheimer's disease during sleep and wakefulness

by Frontiers JournalsPhotobiomodulation of brain cleansing of beta-amyloid during sleep. Credit: Frontiers JournalsPhotobiomodulation during sleep turns the brain into a washing machine, helping to cl

Updated on:March 02,2024